Conference item
Effect of ribavirin and interferon on the outcome of critically ill patients with mers
- Abstract:
- Interferon and ribavirin have been used in the treatment of the Middle East Respiratory Syndrome (MERS), but the efficacy of this therapy remains uncertain. Existing data are limited by the lack of adjustment to time-dependent covariates at the time of initiation of therapy. This study objective is to examine the association of ribavirin/interferon in critically ill MERS patients using marginal structural models.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
- Publisher:
- American Thoracic Society
- Host title:
- American Thoracic Society (ATS) 2017 International Conference
- Journal:
- American Thoracic Society (ATS) 2017 International Conference More from this journal
- Publication date:
- 2017-05-01
- ISSN:
-
1073-449X
- Pubs id:
-
pubs:718422
- UUID:
-
uuid:4d5543b3-8e35-4c2d-ae22-875dd42e6dc3
- Local pid:
-
pubs:718422
- Source identifiers:
-
718422
- Deposit date:
-
2017-08-17
- ARK identifier:
Terms of use
- Copyright date:
- 2017
If you are the owner of this record, you can report an update to it here: Report update to this record